Overview

to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers

Status:
Enrolling by invitation

Trial end date:
2021-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Luye Pharma Group Ltd.